JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 3, 2003; DOI: 10.1124/jpet.103.052605


0022-3565/03/3071-152-159$20.00
JPET 307:152-159, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.052605v1
307/1/152    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alencar, J. L.
Right arrow Articles by Muller, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alencar, J. L.
Right arrow Articles by Muller, B.

CARDIOVASCULAR

S-Nitrosating Nitric Oxide Donors Induce Long-Lasting Inhibition of Contraction in Isolated Arteries

Jacicarlos L. Alencar, Irina Lobysheva, Karel Chalupsky, Michel Geffard, Françoise Nepveu, Jean-Claude Stoclet, and Bernard Muller

Université Louis Pasteur, Faculté de Pharmacie, Pharmacologie and Physico-Chimie, Unité Mixte Recherche Centre National de la Recherche Scientifique, Illkirch, France (J.L.A., K.C., J.-C.S., B.M.); Universidade Federal da Paraíba, Laboratório de Tecnologia Farmacêutica, Departamento de Ciências Básicas da Saúde, Campina Grande, Brazil (J.L.A.); Université Paul Sabatier, Faculté des Sciences Pharmaceutiques, Unité Mixte de Recherche, Institut de Recherche pour le Developpement, Toulouse, France (I.L., F.N.); Ecole Pratique des Hautes Etudes, Physique des Interactions Ondes-Matières, Pessac, France (M.G.); and Université Victor Segalen, Laboratoire de Pharmacologie, Unité de Formation et de Recherche Sciences Pharmaceutiques and Equipe Mixte Institut National de la Santé et de la Recherche Médicale, Bordeaux, France (B.M.)

The ability of various nitric oxide (NO) donors to induce long-lasting inhibition of contraction in isolated arteries was compared. All the studied compounds elicited a relaxant effect in rat aortic rings precontracted with norepinephrine (NE). Almost maximal relaxation was obtained with 1 µM of each compound. The S-nitrosating agents S-nitrosoglutathione (GSNO), S-nitroso-N-acetylpenicillamine, S-nitroso-N-acetylcysteine, and sodium nitroprusside (1 µM) produced a decrease of the maximal effect of NE that persisted after removal of the drug. This hyporesponsiveness to NE was associated with a relaxant effect of N-acetylcysteine, a low-molecular weight thiol that can displace NO from cysteine-NO bonds. Such modifications of contraction were not observed in aortic rings previously exposed to 1 µM S-nitrosocysteine, glyceryl trinitrate, 3-morpholinosydnonimine, or 2-(N,N-diethylamino)-diazenolate-2-oxide (DEA-NO). The same differential effects of GSNO and DEA-NO on contraction were also observed in porcine coronary arteries. Rat aortic rings previously exposed to 100 µM GSNO, but not to 100 µM DEA-NO, displayed a persistent increase in NO content (determined by NO spin trapping) and cysteine-NO residues (determined by immunostaining with an anti-cysteine-NO antiserum). The GSNO-induced increase in cysteine-NO residues in aortic tissue was prevented by the thiolmodifying agent p-hydroxymercuribenzoic acid. This study shows that in isolated arteries, the effects of S-nitrosating agents differed from those of other NO-donating agents. S- Nitrosating agents induced a persistent inhibition of contraction, which was attributed to the formation of releasable NO stores by S-nitrosation of tissue thiols. These differential effects of NO donors may be important for orientating their therapeutic indications.


Received April 3, 2003; accepted June 17, 2003.

Address correspondence to: Prof. Bernard Muller, Laboratoire de Pharmacologie, UFR Sciences Pharmaceutiques/INSERM EMI 0356, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France. E-mail: bernard.muller{at}phcodyn.ubordeaux2.fr




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nozik-Grayck, E. J. Whalen, J. S. Stamler, T. J. McMahon, P. Chitano, and C. A. Piantadosi
S-nitrosoglutathione inhibits {alpha}1-adrenergic receptor-mediated vasoconstriction and ligand binding in pulmonary artery
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L136 - L143.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.